Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    • Implants / Devices
    • Stryker awarded 248.7...

    Stryker awarded 248.7 million dollar in patent case against Zimmer

    Written by Ruby Khatun Khatun Published On 2017-07-16T10:03:34+05:30  |  Updated On 16 July 2017 10:03 AM IST
    Stryker awarded 248.7 million dollar in patent case against Zimmer

    A U.S. judge has increased the amount medical device maker Zimmer Biomet Holdings Inc must pay Stryker Corp for infringing patents on a surgical cleaning wand to $248.7 million following a ruling by the U.S. Supreme Court.


    The ruling by U.S. District Judge Robert Jonker in Grand Rapids, Michigan, on Wednesday came after the Supreme Court in June 2016 ruled for Stryker in finding that judges should have more discretion to boost penalties in patent infringement cases.


    Stryker declined to comment on Thursday. Zimmer did not immediately respond to a request for comment.


    The ruling came in a lawsuit filed in 2010 by Kalamazoo, Michigan-based Stryker that claimed its competitor's Pulsavac Plus device for cleaning wounds during orthopedic surgical procedures infringed three of its patents.


    In 2013, a federal jury awarded Stryker $70 million in lost profits and found Warsaw, Indiana-based Zimmer's conduct to have been willful.


    Jonker later that year ruled Stryker deserved triple damages based on the "flagrancy and scope of Zimmer's infringement." With other fees, the award came to $228 million.


    On appeal, the U.S. Federal Circuit Court of Appeals, the nation's top patent court, upheld the jury's finding of infringement, but reversed on willfulness, which had been the basis for tripling the damages.


    But the U.S. Supreme Court in June 2016 said that court's test for determining willful infringement was too rigid and allowed some egregious infringers to escape liability.


    The Federal Circuit in September subsequently sent the case back to Jonker to determine whether Stryker deserved enhanced patent infringement damages under the Supreme Court's changed standard for awarding them.


    In his decision on Wednesday, Jonker reaffirmed his original award of enhanced damages and attorneys' fees.


    "In simplest terms, the Court believes that its and the jury's original fact findings against Zimmer, coupled with multiple legal changes that actually make it easier to enhance damages and make exceptional case findings, fully support the Court's original awards in the case," Jonker wrote.


    The case is Stryker Corp, et al, v. Zimmer Inc, et al, U.S. District Court, Western District of Michigan, No. 10-cv-1223.




    Reporting by Nate Raymond in Boston; Editing by Bernadette Baum



    Judge Robert Jonkerlawsuitorthopedic surgical proceduresorthopedicspatentpatent infringement casePulsavac Plus deviceStrykerSupreme CourtZimmerZimmer Biomet
    Source : REUTERS

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Ruby Khatun Khatun
    Ruby Khatun Khatun
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok